Skip to main content

Table 1 Demographic and clinical variables in the study population (n = 226)

From: Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis

Variable

Labels

n

%

Gender

Males

132

61.4

 

Females

83

38.6

Age

≤ 60

87

40.5

 

60+

128

59.5

PS

≥ 90

25

11.1

 

= 80

75

33.2

 

= 70

74

19.5

 

= 60

40

17.7

 

≤ 50

42

18.6

Location

Head

147

68.4

 

Body

52

24.2

 

Back ('tail")

16

7.4

Therapy

Chemotherapy and surgery

53

24.7

 

Chemotherapy only

65

30.2

 

Surgery only

24

11.2

 

None

73

34.0

Surgery

Yes

77

35.8

 

No

138

64.2

Chemotherapy

Yes

118

54.9

 

No

97

45.1

Ploidy

< 2.2

20

8.8

 

2.2–3.6

86

38.1

 

>3.6

120

53.1

Amylase

Yes

23

10.7

 

No

192

89.3

Grading

High

14

6.5

 

Medium

187

87.0

 

Low

14

6.5

Primary tumor extent

1

15

7.0

 

2

60

27.9

 

3

77

35.8

 

4

63

29.3

CEA

≤ 5 mg/dL

72

33.5

 

>5 mg/dL

143

66.5

CA 19-9

≤ 30 × normal

30

14.0

 

>30 × normal

185

86.0

Thrombophlebitis

Yes

105

48.8

 

No

110

51.2

Diabetes

Yes

199

92.6

 

No

16

7.4

CRP

Normal

150

69.8

 

Increased

35

16.3

 

Greatly increased

30

14.0

Steatorrhoea

Yes

99

46.0

 

No

116

54.0

Albumin

Yes

114

53.0

 

No

101

47.0

Epoetin

Yes

36

16.7

 

No

179

83.3

Transfusion

Yes

61

28.4

 

No

154

71.6

Weight loss

None

62

28.8

 

1–5%

31

14.4

 

6–10%

58

27.0

 

>10%

64

29.8

Pain

None

50

23.3

 

Pain 1

84

39.1

 

Pain 2

55

25.6

 

Pain 3

26

12.1

Metastases

None

86

40.0

 

LN

37

17.2

 

LIV

7

3.3

 

AB

29

13.5

 

LN-AB

30

14.0

 

LIV-LN-AB

26

12.1

Jaundice

Yes

46

21.4

 

No

169

78.6

  1. AB, abdominal metastasis; CA 19-9, cancer antigen 19-9; CEA, carcinoembryonic antigen; CRP, C-reactive protein; LIV, liver metastasis; LN, lymph node metastasis; 1: tumor < 2 cm confined to the panreas, 2: tumor > 2 cm confined to the pancreas, 3: invasion of adjacent tissues by tumor, 4: invasion of adjacent organs.